Impact of biologic therapies and small molecules on the risk of major adverse cardiovascular events in patients with inflammatory bowel diseases: systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Impact of biologic therapies and small molecules on the risk of major adverse cardiovascular events in patients with inflammatory bowel diseases: systematic review and meta-analysis of randomized controlled trials

Published:2023-04-10 Issue:5 Volume:17 Page:469-477
ISSN:1747-4124
Container-title:Expert Review of Gastroenterology & Hepatology
language:en
Short-container-title:Expert Review of Gastroenterology & Hepatology

Author:

Shehab Mohammad¹^ORCID,Alrashed Fatema²,Alkazemi Afrah²,Lakatos Peter L³,Bessissow Talat³

Affiliation:

1. Division of Gastroenterology, Department of Internal Medicine, Mubarak Alkabeer University Hospital, Kuwait University, Jabriya, Kuwait

2. Department of Pharmacy Practice, Faculty of Pharmacy, Kuwait University, Jabriya, Kuwait

3. Division of Gastroenterology and Hepatology, Department of Medicine, McGill University Health Center, Montreal, Canada

Publisher

Informa UK Limited

Subject

Gastroenterology,Hepatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474124.2023.2194631

Reference25 articles.

1. Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis

2. Systematic review: outcomes and adverse events from randomised trials in Crohn's disease

3. Cardiovascular Complications in Inflammatory Bowel Disease

4. Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK

5. Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Effectiveness of Thiopurines and Small Molecules in Elderly Patients with Inflammatory Bowel Diseases;Journal of Clinical Medicine;2024-08-09

2. Risk of Major Adverse Cardiovascular Events in Immune-Mediated Inflammatory Disorders on Biologics and Small Molecules: Network Meta-Analysis;Clinical Gastroenterology and Hepatology;2023-10

3. Janus kinase inhibitors in autoimmune bullous diseases;Frontiers in Immunology;2023-07-10

4. Efficacy and Safety of Biological Therapies and JAK Inhibitors in Older Patients with Inflammatory Bowel Disease;Cells;2023-06-26